Login Register Cart 0
Generic placeholder image

Protein & Peptide Letters

Editor-in-Chief

ISSN (Print): 0929-8665
ISSN (Online): 1875-5305

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

STAM-binding Protein-like 1 Promotes Growth and Migration of Colorectal Cancer by NF-κB Pathway

Author(s): Xinghua Zhou, Yue Cheng, Jian Kang and Gang Mao*

Volume 30, Issue 12, 2023

Published on: 24 November, 2023

Page: [1058 - 1066] Pages: 9

DOI: 10.2174/0109298665272785231103104118

Price: $65

Abstract

Background: STAM-binding protein-like 1 (STAMBPL1) functions as a deubiquitinase to cleave Lys63 ubiquitin linkage, and is associated with cancer dissemination and progression. The role of STAMBPL1 in colorectal cancer (CRC) remains unclear.

Methods: STAMBPL1 expression was determined by western blot and qRT-PCR. Cell proliferation was detected by colony formation and MTT assays, and apoptosis was assessed by flow cytometry. The metastasis was evaluated by transwell and wound healing assays. An animal xenograft experiment was used to investigate the effect of STAMBPL1 on tumor growth.

Results: The expression of STAMBPL1 was elevated in CRC cells. Knockdown of STAMBPL1 reduced cell viability of CRC and suppressed the proliferation, invasion, and migration. Apoptosis of CRC was induced by silence of STAMBPL1. Tumor growth of CRC was also suppressed by the silence of STAMBPL1. Knockdown of STAMBPL1 increased IκB and decreased phosphorylation of IκB to reduce p65 phosphorylation.

Conclusion: Knockdown of STAMBPL1 inhibited cell growth and metastasis of CRC through inactivation of the NF-κB pathway.

Keywords: STAMBPL1, CRC, proliferation, metastasis, NF-κB, tumor growth.

« Previous Next »
Graphical Abstract

[1]
Testa, U.; Pelosi, E.; Castelli, G. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med. Sci., 2018, 6(2), 31.
[http://dx.doi.org/10.3390/medsci6020031] [PMID: 29652830]
[2]
Rawla, P.; Sunkara, T.; Barsouk, A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz. Gastroenterol., 2019, 14(2), 89-103.
[http://dx.doi.org/10.5114/pg.2018.81072] [PMID: 31616522]
[3]
Dekker, E.; Tanis, P.J.; Vleugels, J.L.A.; Kasi, P.M.; Wallace, M.B. Colorectal cancer. Lancet, 2019, 394(10207), 1467-1480.
[http://dx.doi.org/10.1016/S0140-6736(19)32319-0] [PMID: 31631858]
[4]
Poondla, N.; Chandrasekaran, A.P.; Kim, K.S.; Ramakrishna, S. Deubiquitinating enzymes as cancer biomarkers: New therapeutic opportunities? BMB Rep., 2019, 52(3), 181-189.
[http://dx.doi.org/10.5483/BMBRep.2019.52.3.048] [PMID: 30760385]
[5]
Shrestha, R.K.; Ronau, J.A.; Davies, C.W.; Guenette, R.G.; Strieter, E.R.; Paul, L.N.; Das, C. Insights into the mechanism of deubiquitination by JAMM deubiquitinases from cocrystal structures of the enzyme with the substrate and product. Biochemistry, 2014, 53(19), 3199-3217.
[http://dx.doi.org/10.1021/bi5003162] [PMID: 24787148]
[6]
Pan, X.; Wu, S.; Wei, W.; Chen, Z.; Wu, Y.; Gong, K. Structural and functional basis of JAMM deubiquitinating enzymes in disease. Biomolecules, 2022, 12(7), 910.
[http://dx.doi.org/10.3390/biom12070910] [PMID: 35883466]
[7]
Zhong, G.; Li, H.; Shan, T.; Zhang, N. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro. Int. J. Clin. Exp. Pathol., 2015, 8(3), 2809-2815.
[PMID: 26045788]
[8]
Lavorgna, A.; Harhaj, E.W. An RNA interference screen identifies the Deubiquitinase STAMBPL1 as a critical regulator of human T-cell leukemia virus type 1 tax nuclear export and NF-κB activation. J. Virol., 2012, 86(6), 3357-3369.
[http://dx.doi.org/10.1128/JVI.06456-11] [PMID: 22258247]
[9]
Chen, X.; Shi, H.; Bi, X.; Li, Y.; Huang, Z. Targeting the deubiquitinase STAMBPL1 triggers apoptosis in prostate cancer cells by promoting XIAP degradation. Cancer Lett., 2019, 456, 49-58.
[http://dx.doi.org/10.1016/j.canlet.2019.04.020] [PMID: 31004702]
[10]
Ambroise, G.; Yu, T.; Zhang, B.; Kacal, M.; Hao, Y.; Queiroz, A.L.; Ouchida, A.T.; Lindskog, C.; Norberg, E.; Vakifahmetoglu-Norberg, H. Systematic analysis reveals a functional role for STAMBPL1 in the epithelial–mesenchymal transition process across multiple carcinomas. Br. J. Cancer, 2020, 123(7), 1164-1177.
[http://dx.doi.org/10.1038/s41416-020-0972-x] [PMID: 32636467]
[11]
Liu, T.; Zhang, L.; Joo, D.; Sun, S.C. NF-κB signaling in inflammation. Signal Transduct. Target. Ther., 2017, 2(1), 17023.
[http://dx.doi.org/10.1038/sigtrans.2017.23]
[12]
Slattery, M.L.; Fitzpatrick, F.A. Convergence of hormones, inflammation, and energy-related factors: A novel pathway of cancer etiology. Cancer Prev. Res., 2009, 2(11), 922-930.
[http://dx.doi.org/10.1158/1940-6207.CAPR-08-0191] [PMID: 19892662]
[13]
Soleimani, A.; Rahmani, F.; Ferns, G.A.; Ryzhikov, M.; Avan, A.; Hassanian, S.M. Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer. Gene, 2020, 726144132
[http://dx.doi.org/10.1016/j.gene.2019.144132] [PMID: 31669643]
[14]
Sharma, A.; Khan, H.; Singh, T.; Grewal, A.; Najda, A.; Kawecka-Radomska, M.; Kamel, M.; Altyar, A.; Abdel-Daim, M. Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling. Int. J. Mol. Sci., 2021, 22(21), 11971.
[http://dx.doi.org/10.3390/ijms222111971] [PMID: 34769401]
[15]
Guo, Z.; Wang, Y.; Zhao, Y.; Shu, Y.; Liu, Z.; Zhou, H. The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer. Gene, 2018, 687.
[PMID: 30468907]
[16]
Jumpertz, S.; Hennes, T.; Asare, Y.; Schütz, A.K.; Bernhagen, J. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells. Cell. Signal., 2017, 34, 38-46.
[http://dx.doi.org/10.1016/j.cellsig.2017.02.013] [PMID: 28229932]
[17]
Wang, D; Xu, C; Yang, W; Chen, J; Ou, Y; Guan, Y E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression. Molecular cell., 2022, 82(4), 770-784.
[http://dx.doi.org/10.1016/j.molcel.2022.01.002]
[18]
Pavlič, A.; Urh, K.; Štajer, K.; Boštjančič, E.; Zidar, N. Epithelial-mesenchymal transition in colorectal carcinoma: Comparison between primary tumor, lymph node and liver metastases. Front. Oncol., 2021, 11(1504)662806
[http://dx.doi.org/10.3389/fonc.2021.662806] [PMID: 34046357]
[19]
Kishore, C.; Sundaram, S.; Karunagaran, D. Vitamin K3 (menadione) suppresses epithelial-mesenchymal-transition and Wnt signaling pathway in human colorectal cancer cells. Chem. Biol. Interact., 2019, 309108725
[http://dx.doi.org/10.1016/j.cbi.2019.108725] [PMID: 31238027]
[20]
Sun, J.; Zhang, Z.; Chen, J.; Xue, M.; Pan, X. ELTD1 promotes invasion and metastasis by activating MMP2 in colorectal cancer. Int. J. Biol. Sci., 2021, 17(12), 3048-3058.
[http://dx.doi.org/10.7150/ijbs.62293] [PMID: 34421349]
[21]
Yu, D.J.; Qian, J.; Jin, X.; Li, J.; Guo, C.X.; Yue, X.C. STAMBPL1 knockdown has antitumour effects on gastric cancer biological activities. Oncol. Lett., 2019, 18(5), 4421-4428.
[http://dx.doi.org/10.3892/ol.2019.10789] [PMID: 31611951]
[22]
Lavorgna, A.; Harhaj, E.W. STAMBPL1 is a deubiquitinating enzyme that regulates HTLV-I Tax subcellular localization and NF-kB activation. Retrovirology, 2011, 8(S1), A190.
[http://dx.doi.org/10.1186/1742-4690-8-S1-A190]

Rights & Permissions Print Cite
Article Metrics
19
1
© 2024 Bentham Science Publishers | Privacy Policy